TY - JOUR AU - Yang, V. W. AU - Lewis, J. AU - Wang, T. C. AU - Rustgi, A. K. PY - 2010 DA - 2010// TI - Colon cancer: an update and future directions JO - Gastroenterology VL - 138 UR - https://doi.org/10.1053/j.gastro.2010.03.007 DO - 10.1053/j.gastro.2010.03.007 ID - Yang2010 ER - TY - JOUR AU - Aghili, M. AU - Izadi, S. AU - Madani, H. AU - Mortazavi, H. PY - 2010 DA - 2010// TI - Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer JO - Asia Pac J Clin Oncol VL - 6 UR - https://doi.org/10.1111/j.1743-7563.2010.01275.x DO - 10.1111/j.1743-7563.2010.01275.x ID - Aghili2010 ER - TY - JOUR AU - Gallo, R. C. AU - Whang-Peng, J. AU - Adamson, R. H. PY - 1971 DA - 1971// TI - Studies on the antitumor activity, mechanism of action, and cell cycle effects of camptothecin JO - J Natl Cancer Inst VL - 46 ID - Gallo1971 ER - TY - JOUR AU - Husain, I. AU - Mohler, J. L. AU - Seigler, H. F. AU - Besterman, J. M. PY - 1994 DA - 1994// TI - Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy JO - Cancer Res VL - 54 ID - Husain1994 ER - TY - JOUR AU - Boonsong, A. AU - Curran, S. AU - McKay, J. A. AU - Cassidy, J. AU - Murray, G. I. AU - McLeod, H. L. PY - 2002 DA - 2002// TI - Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases JO - Hum Pathol VL - 33 UR - https://doi.org/10.1053/hupa.2002.129202 DO - 10.1053/hupa.2002.129202 ID - Boonsong2002 ER - TY - JOUR AU - Alagoz, M. AU - Gilbert, D. C. AU - El-Khamisy, S. AU - Chalmers, A. J. PY - 2012 DA - 2012// TI - DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets JO - Curr Med Chem VL - 19 UR - https://doi.org/10.2174/092986712802002590 DO - 10.2174/092986712802002590 ID - Alagoz2012 ER - TY - JOUR AU - Gilbert, D. C. AU - Chalmers, A. J. AU - El-Khamisy, S. F. PY - 2012 DA - 2012// TI - Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets JO - Br J Cancer VL - 106 UR - https://doi.org/10.1038/bjc.2011.498 DO - 10.1038/bjc.2011.498 ID - Gilbert2012 ER - TY - JOUR AU - Kessel, D. AU - Bosmann, H. B. AU - Lohr, K. PY - 1972 DA - 1972// TI - Camptothecin effects on DNA synthesis in murine leukemia cells JO - Biochim Biophys Acta VL - 269 UR - https://doi.org/10.1016/0005-2787(72)90429-7 DO - 10.1016/0005-2787(72)90429-7 ID - Kessel1972 ER - TY - JOUR AU - Ling, Y. H. AU - Tseng, M. T. AU - Nelson, J. A. PY - 1991 DA - 1991// TI - Differentiation induction of human promyelocytic leukemia cells by 10-hydroxycamptothecin, a DNA topoisomerase I inhibitor JO - Differentiation VL - 46 UR - https://doi.org/10.1111/j.1432-0436.1991.tb00873.x DO - 10.1111/j.1432-0436.1991.tb00873.x ID - Ling1991 ER - TY - JOUR AU - Ling, Y. H. AU - Andersson, B. S. AU - Nelson, J. A. PY - 1990 DA - 1990// TI - DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells JO - Cancer Biochem Biophys VL - 11 ID - Ling1990 ER - TY - JOUR AU - Ulukan, H. AU - Swaan, P. W. PY - 2002 DA - 2002// TI - Camptothecins: a review of their chemotherapeutic potential JO - Drugs VL - 62 UR - https://doi.org/10.2165/00003495-200262140-00004 DO - 10.2165/00003495-200262140-00004 ID - Ulukan2002 ER - TY - JOUR AU - Garcia-Carbonero, R. AU - Supko, J. G. PY - 2002 DA - 2002// TI - Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins JO - Clin Cancer Res VL - 8 ID - Garcia-Carbonero2002 ER - TY - JOUR AU - Chen, X. AU - Ran, Z. H. AU - Tong, J. L. AU - Nie, F. AU - Zhu, M. M. AU - Xu, X. T. AU - Xiao, S. D. PY - 2011 DA - 2011// TI - RNA interference (RNAi) of Ufd1 protein can sensitize a hydroxycamptothecin-resistant colon cancer cell line SW1116/HCPT to hydroxycamptothecin JO - J Dig Dis VL - 12 UR - https://doi.org/10.1111/j.1751-2980.2011.00478.x DO - 10.1111/j.1751-2980.2011.00478.x ID - Chen2011 ER - TY - JOUR AU - Wu, X. M. AU - Shao, X. Q. AU - Meng, X. X. AU - Zhang, X. N. AU - Zhu, L. AU - Liu, S. X. AU - Lin, J. AU - Xiao, H. S. PY - 2011 DA - 2011// TI - Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin-resistant gastric cancer cells JO - Acta Pharmacol Sin VL - 32 UR - https://doi.org/10.1038/aps.2010.204 DO - 10.1038/aps.2010.204 ID - Wu2011 ER - TY - JOUR AU - Ping, Y. H. AU - Lee, H. C. AU - Lee, J. Y. AU - Wu, P. H. AU - Ho, L. K. AU - Chi, C. W. AU - Lu, M. F. AU - Wang, J. J. PY - 2006 DA - 2006// TI - Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer JO - Oncol Rep VL - 15 ID - Ping2006 ER - TY - JOUR AU - Ling, Y. H. AU - Xu, B. PY - 1993 DA - 1993// TI - Inhibition of phosphorylation of histone H1 and H3 induced by 10-hydroxycamptothecin, DNA topoisomerase I inhibitor, in murine ascites hepatoma cells JO - Zhongguo Yao Li Xue Bao VL - 14 ID - Ling1993 ER - TY - JOUR AU - Zhang, X. W. AU - Jiang, J. F. AU - Xu, B. PY - 2000 DA - 2000// TI - Differentiation-inducing action of 10-hydroxycamptothecin on human hepatoma Hep G2 cells JO - Acta Pharmacol Sin VL - 21 ID - Zhang2000 ER - TY - JOUR AU - Zhang, Z. W. AU - Patchett, S. E. AU - Farthing, M. J. PY - 2000 DA - 2000// TI - Topoisomerase I inhibitor (camptothecin)-induced apoptosis in human gastric cancer cells and the role of wild-type p53 in the enhancement of its cytotoxicity JO - Anticancer Drugs VL - 11 UR - https://doi.org/10.1097/00001813-200010000-00013 DO - 10.1097/00001813-200010000-00013 ID - Zhang2000 ER - TY - JOUR AU - Zhang, G. AU - Ding, L. AU - Renegar, R. AU - Wang, X. AU - Lu, Q. AU - Huo, S. AU - Chen, Y. H. PY - 2011 DA - 2011// TI - Hydroxycamptothecin-loaded Fe3O4 nanoparticles induce human lung cancer cell apoptosis through caspase-8 pathway activation and disrupt tight junctions JO - Cancer Sci VL - 102 UR - https://doi.org/10.1111/j.1349-7006.2011.01930.x DO - 10.1111/j.1349-7006.2011.01930.x ID - Zhang2011 ER - TY - JOUR AU - Hu, W. AU - Zhang, C. AU - Fang, Y. AU - Lou, C. PY - 2011 DA - 2011// TI - Anticancer properties of 10-hydroxycamptothecin in a murine melanoma pulmonary metastasis model in vitro and in vivo JO - Toxicol In Vitro VL - 25 UR - https://doi.org/10.1016/j.tiv.2010.11.009 DO - 10.1016/j.tiv.2010.11.009 ID - Hu2011 ER - TY - JOUR AU - Yao, Y. AU - Sun, Y. J. AU - Zhao, H. AU - Guo, Y. W. AU - Lin, F. AU - Cai, X. AU - Tang, X. C. AU - Tang, L. N. AU - Zhang, W. PY - 2006 DA - 2006// TI - Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer JO - Chin Med J (Engl) VL - 119 ID - Yao2006 ER - TY - JOUR AU - Sinha, V. R. AU - Honey, G. PY - 2012 DA - 2012// TI - Critical aspects in rationale design of fluorouracil-based adjuvant therapies for the management of colon cancer JO - Crit Rev Ther Drug Carrier Syst VL - 29 UR - https://doi.org/10.1615/CritRevTherDrugCarrierSyst.v29.i2.10 DO - 10.1615/CritRevTherDrugCarrierSyst.v29.i2.10 ID - Sinha2012 ER - TY - JOUR AU - Medema, J. P. AU - Scaffidi, C. AU - Krammer, P. H. AU - Peter, M. E. PY - 1998 DA - 1998// TI - Bcl-xL acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.6.3388 DO - 10.1074/jbc.273.6.3388 ID - Medema1998 ER - TY - JOUR AU - Ashkenazi, A. AU - Dixit, V. M. PY - 1998 DA - 1998// TI - Death receptors: signaling and modulation JO - Science VL - 281 UR - https://doi.org/10.1126/science.281.5381.1305 DO - 10.1126/science.281.5381.1305 ID - Ashkenazi1998 ER - TY - JOUR AU - Fulda, S. AU - Scaffidi, C. AU - Susin, S. A. AU - Krammer, P. H. AU - Kroemer, G. AU - Peter, M. E. AU - Debatin, K. M. PY - 1998 DA - 1998// TI - Activation of mitochondria and release of mitochondrial apoptogenic factors by betulinic acid JO - J Biol Chem VL - 273 UR - https://doi.org/10.1074/jbc.273.51.33942 DO - 10.1074/jbc.273.51.33942 ID - Fulda1998 ER - TY - JOUR AU - Kroemer, G. AU - Reed, J. C. PY - 2000 DA - 2000// TI - Mitochondrial control of cell death JO - Nat Med VL - 6 UR - https://doi.org/10.1038/74994 DO - 10.1038/74994 ID - Kroemer2000 ER - TY - JOUR AU - Jin, Z. AU - El-Deiry, W. S. PY - 2005 DA - 2005// TI - Overview of cell death signaling pathways JO - Cancer Biol Ther VL - 4 UR - https://doi.org/10.4161/cbt.4.2.1508 DO - 10.4161/cbt.4.2.1508 ID - Jin2005 ER - TY - JOUR AU - Takeba, Y. AU - Sekine, S. AU - Kumai, T. AU - Matsumoto, N. AU - Nakaya, S. AU - Tsuzuki, Y. AU - Yanagida, Y. AU - Nakano, H. AU - Asakura, T. AU - Ohtsubo, T. AU - Kobayashi, S. PY - 2007 DA - 2007// TI - Irinotecan-induced apoptosis is inhibited by increased P-glycoprotein expression and decreased p53 in human hepatocellular carcinoma cells JO - Biol Pharm Bull VL - 30 UR - https://doi.org/10.1248/bpb.30.1400 DO - 10.1248/bpb.30.1400 ID - Takeba2007 ER - TY - JOUR AU - Wang, S. AU - El-Deiry, W. S. PY - 2003 DA - 2003// TI - Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy JO - Proc Natl Acad Sci USA VL - 100 UR - https://doi.org/10.1073/pnas.2435285100 DO - 10.1073/pnas.2435285100 ID - Wang2003 ER - TY - JOUR AU - Straub, C. S. PY - 2011 DA - 2011// TI - Targeting IAPs as an approach to anti-cancer therapy JO - Curr Top Med Chem VL - 11 UR - https://doi.org/10.2174/156802611794072623 DO - 10.2174/156802611794072623 ID - Straub2011 ER - TY - JOUR AU - Fulda, S. AU - Vucic, D. PY - 2012 DA - 2012// TI - Targeting IAP proteins for therapeutic intervention in cancer JO - Nat Rev Drug Discov VL - 11 UR - https://doi.org/10.1038/nrd3627 DO - 10.1038/nrd3627 ID - Fulda2012 ER - TY - JOUR AU - Tu, S. P. AU - Cui, J. T. AU - Liston, P. AU - Huajiang, X. AU - Xu, R. AU - Lin, M. C. AU - Zhu, Y. B. AU - Zou, B. AU - Ng, S. S. AU - Jiang, S. H. AU - Xia, H. H. AU - Wong, W. M. AU - Chan, A. O. AU - Yuen, M. F. AU - Lam, S. K. AU - Kung, H. F. AU - Wong, B. C. PY - 2005 DA - 2005// TI - Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant JO - Gastroenterology VL - 128 UR - https://doi.org/10.1053/j.gastro.2004.11.058 DO - 10.1053/j.gastro.2004.11.058 ID - Tu2005 ER - TY - JOUR AU - Ge, Q. X. AU - Li, Y. Y. AU - Nie, Y. Q. AU - Zuo, W. G. AU - Du, Y. L. PY - 2013 DA - 2013// TI - Expression of survivin and its four splice variants in colorectal cancer and its clinical significances JO - Med Oncol VL - 30 UR - https://doi.org/10.1007/s12032-013-0535-6 DO - 10.1007/s12032-013-0535-6 ID - Ge2013 ER - TY - JOUR AU - Zhu, N. AU - Gu, L. AU - Findley, H. W. AU - Li, F. AU - Zhou, M. PY - 2004 DA - 2004// TI - An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy JO - Oncogene VL - 23 UR - https://doi.org/10.1038/sj.onc.1208038 DO - 10.1038/sj.onc.1208038 ID - Zhu2004 ER - TY - JOUR AU - Folprecht, G. AU - Seymour, M. T. AU - Saltz, L. AU - Douillard, J. Y. AU - Hecker, H. AU - Stephens, R. J. AU - Maughan, T. S. AU - Van Cutsem, E. AU - Rougier, P. AU - Mitry, E. AU - Schubert, U. AU - Köhne, C. H. PY - 2008 DA - 2008// TI - Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer: combined analysis of 2,691 patients in randomized controlled trials JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.14.0509 DO - 10.1200/JCO.2007.14.0509 ID - Folprecht2008 ER -